SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH

• CERAMEDIX HOLDING, LLC

  UEI JLZSJRJVKJ49

  $179.4K

  Subcontractor to this prime · 1 sub-award · latest Jun 27, 2025

  • National Institutes of Health
  • “TEST EFFICACY OF ANTI-CERAMIDE ANTIBODY PLUS NEULASTA IN A PARTIAL BODY IRRADIATION MOUSE MODEL”
• ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

  UEI C8H9CNG1VBD9

  $151.4K

  Subcontractor to this prime · 1 sub-award · latest Jul 16, 2026

  • National Institutes of Health
  • “IF300302118-940002 (OPTION 4) IF300302188-940002 (OPTION 5) MARTA LUKSZA, PH.D., AT MEMORIAL SLOAN KETTERING CANCER CENTER (MSKCC), WILL CONDUCT COMPUTATIONAL ANALYSES OF RESPIRATORY VIRUS EVOLUTION WITH A FOCUS ON INFLUENZA VIRUSES AND SARS-COV-2. THE PROJECT WILL PURSUE THREE DEFINED OBJECTIVES: (1) DEVELOP EFFICIENT ALGORITHMS AND PIPELINES FOR PHYLOGENY AND REASSORTMENT RECONSTRUCTION; (2) PERFORM COMPUTATIONAL FITNESS ANALYSIS OF CIRCULATING INFLUENZA STRAINS; AND (3) PROVIDE TOOLS FOR VISUALIZATION OF GLOBAL AND REGIONAL PHYLOGENIES OF RESPIRATORY VIRUSES. ACTIVITIES WILL INCLUDE LARGE-SCALE TIME-RESOLVED PHYLOGENETIC RECONSTRUCTION USING VIRAL SEQUENCE DATA FROM GISAID AND THE GOTHAM COHORT, DEVELOPMENT AND OPTIMIZATION OF MULTI-SEGMENT REASSORTMENT DETECTION METHODS, AND APPLICATION OF ESTABLISHED FITNESS MODELING FRAMEWORKS TO ASSESS THE EVOLUTIONARY TRAJECTORIES OF CIRCULATING STRAINS. THE PROJECT WILL ALSO MAINTAIN AND EXPAND WEB-BASED VISUALIZATION TOOLS TO DISSEMINATE PHYLOGENETIC, REASSORTMENT, AND FITNESS ANALYSES AND WILL SUPPORT COORDINATION WITH EXPERIMENTAL LABORATORIES THROUGH IDENTIFICATION AND SELECTION OF REPRESENTATIVE VIRAL ISOLATES FOR PHENOTYPIC FOLLOW-UP. ALL WORK WILL BE PERFORMED AT MSKCC USING EXISTING COMPUTATIONAL INFRASTRUCTURE AND CURATED VIRAL SURVEILLANCE DATASETS.”
• KAISER FOUNDATION HOSPITALS

  UEI P1RTMASB37B5

  $92.1K

  Subcontractor to this prime · 1 sub-award · latest Jul 1, 2026

  • Office of the Assistant Secretary for Financial Resources
  • “THE CISNET COLORECTAL CANCER WORKING GROUP SHALL CONDUCT A DECISION ANALYSIS USING A COLLABORATIVE MODELING APPROACH TO SUPPORT THE USPSTF SCREENING FOR COLORECTAL CANCER RECOMMENDATION STATEMENT. AS PART OF THIS WORK, A RESEARCH PLAN, DECISION ANALYSIS REPORT, AND MANUSCRIPT WILL BE PRODUCED.”

No reported sub-awards as a prime contractor.

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).

The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.